K.M. Gopakumar, Senior Research and Legal Advisor at Third World Network, discusses the implications of the new patent vaccine waiver introduced in the WTO and how countries like India face political, technical, and policy constraints in accessing medicine.
Ashok Gurung, prior Senior Director of ICI, was a guest co-editor for the peer-reviewed journal CASTE: A Global Journal on Social Exclusion, in a special issue focused [...]
COVID-19 provides an opportunity to reimagine public health systems to focus on access, writes Andrew McDowell, cultural and medical anthropologist at Tulane University.
Development economist, Jayati Ghosh, explains why more than a third of a million COVID-19 cases are being reported in India daily—and what that says about our world.
In the second interview as part of our new series, "Politics of Vaccine Equity: Conversations on the Frontline," public health consultant and lawyer, Rohit Malpani, discusses how since the HIV/AIDS pandemic there has been from a shift from politics to geopolitics, the new role that emerging economies play in the global landscape of COVID-19 vaccine access, and the importance of technology platforms.
In the first interview as part of our new series, "Politics of Vaccine Equity: Conversations on the Frontline," public health expert and senior policy advisor to the People's Vaccine Alliance, Mohga Kamal-Yanni, discusses how countries are at the whim of Big Pharma for supplying COVID-19 vaccines.
Pandemic Discourses launches a new series, "Politics of Vaccine Equity: Conversations on the Frontline," which will interview advocates about the politics and struggle of access to medicines.
In Brazil, radio has been a powerful tool for access to education and information to fight the COVID-19 pandemic, writes Laura Belik, architecture PhD candidate at the University of California Berkeley.
ICI Co-Director Mark Frazier and University of California Irvine History Professor Jeffrey Wasserstrom published a recent op-ed in The Hindu on Hong Kong's withering democracy, [...]
